Imigran Ftab

Sumatriptan, the active ingredient in Imigran Ftab, is a selective serotonin (5‑HT1B/1D) receptor agonist presented as an oral tablet. It is classified as an acute migraine treatment and is used to relieve migraine attacks in adult patients. It is indicated for the rapid relief of migraine symptoms, including headache, nausea and sensitivity to light.

GNH USA supplies Imigran Ftab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for acute migraine therapy. The company adheres to EU GMP standards and offers batch‑tested products with full regulatory documentation.

Sumatriptan is a selective serotonin receptor agonist used for acute migraine management.

Migraine attacks: provides rapid relief of headache and associated nausea, photophobia, and phonophobia. Migraine with aura: aborts migraine attack after aura onset. Acute episodic migraine: reduces severity of migraine symptoms when taken at the first sign of an attack.

Common Side Effects: - Chest discomfort or tightness - Flushing or warmth sensation - Nausea or abdominal pain - Dizziness or vertigo - Tingling or numbness in extremities - Fatigue or drowsiness

Serious or Rare Side Effects: - Serotonin syndrome, especially with other serotonergic agents - Coronary artery vasospasm leading to chest pain - Ischemic stroke or transient ischemic attack - Severe hypertension or hypertensive crisis - Allergic reactions such as rash, angioedema, or anaphylaxis - Cardiac arrhythmias or myocardial infarction

Before initiating therapy, evaluate cardiovascular risk and medical history.

Medical assessment: assess for uncontrolled hypertension, ischemic heart disease, or cerebrovascular disorders. Contraindications: avoid in patients with known hypersensitivity to sumatriptan or other triptans. Drug interactions: review concomitant serotonergic medications to prevent serotonin syndrome. Pregnancy and lactation: safety not established; use only if potential benefit outweighs risk. Store at ambient temperature: keep in original container, protect from moisture and light.

Sumatriptan may interact with several drug classes; review patient medication list.

Major Interactions (Avoid): - MAO inhibitors: increased risk of serotonin syndrome. - Ergot alkaloids: additive vasoconstriction may precipitate ischemia. - Other triptans: combined use can cause severe vasospasm.

Moderate Interactions (Monitor Closely): - SSRIs, SNRIs, or other serotonergic agents: monitor for serotonin syndrome. - Antihypertensive agents: may enhance hypotensive effects. - CYP3A4 inhibitors (e.g., ketoconazole): may raise sumatriptan plasma concentrations.